首页> 中国专利> 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物

用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物

页面导航

摘要
著录项
法律信息
相似文献

摘要

描绘了对来自病原体刚地弓形虫(

著录项

公开/公告号CN103517714A

专利类型发明专利
公开/公告日2014-01-15

原文格式PDF
申请/专利权人英珀特疗法有限公司;
展开▼

申请/专利号CN201180068424.6
发明设计人 D.H.戴维斯;梁小武;P.费尔格纳;
展开▼

申请日2011-12-20
分类号A61K39/012;A61K39/00;
代理机构中国专利代理(香港)有限公司;
代理人林毅斌
地址美国加利福尼亚州
入库时间 2024-02-19 22:18:46

法律信息

法律状态公告日

法律状态信息

法律状态
2017-04-19

专利权的视为放弃 IPC(主分类):A61K39/012 放弃生效日:20170419 申请日:20111220

专利权的视为放弃
2015-09-02

专利申请权的转移 IPC(主分类):A61K39/012 变更前: 变更后: 登记生效日:20150810 申请日:20111220

专利申请权、专利权的转移
2015-01-21

著录事项变更 IPC(主分类):A61K39/012 变更前: 变更后: 申请日:20111220

著录事项变更
2014-02-19

实质审查的生效 IPC(主分类):A61K39/012 申请日:20111220

实质审查的生效
2014-01-15

公开

公开

相似文献

专利
中文文献
外文文献

1. 用于刚地弓形虫感染和弓形体病的诊断和治疗的方法和蛋白抗原组合物 [P] . 中国专利： CN103517714A . 2014-01-15
2. 用于诊断和治疗单纯疱疹病毒1和2型的蛋白质抗原的方法和组合物 [P] . 中国专利： CN104080477A . 2014-10-01
3. Isolated negative-sense single stranded rna virus, isolated or recombinant nucleic acid or its specific functional mpv fragment, vector, host cell, isolated or recombinant proteinaceous molecule or its specific functional mpv fragment, antigen, antibody, method for identifying a viral isolate as a mpv, viral isolate, methods for virologically and serologically diagnosing a mammalian mpv infection, diagnostic kit for diagnosing a mpv infection, uses of a virus, a nucleic acid, a vector, a cell host, a proteinaceous molecule or fragment thereof, an antigen, or an antibody, pharmaceutical composition, methods for treating or preventing an mpv infection and respiratory disease, and for obtaining an antiviral agent useful in the treatment of disease. of the respiratory tract, antiviral agent, use of a viral agent, methods for virologically diagnosing and serum logically a bird apv infection, use of a diagnostic test, and method for detecting an antibody directed against mpv in a sample [P] . BR0206591A . 2005-02-01

机译：分离的负义单链RNA病毒，分离的或重组的核酸或其特定功能的mpv片段，载体，宿主细胞，分离的或重组的蛋白质分子或其特定的功能mpv片段，抗原，抗体，将病毒分离物鉴定为mpv，病毒分离物，用于病毒学和血清学诊断哺乳动物mpv感染的方法，用于诊断mpv感染的诊断试剂盒，病毒，核酸，载体，细胞宿主，蛋白质分子或其片段，抗原的用途，或抗体，药物组合物，用于治疗或预防mpv感染和呼吸道疾病以及获得可用于治疗疾病的抗病毒剂的方法。呼吸道，抗病毒药，病毒药的使用，禽apv感染的病毒学诊断和逻辑诊断方法，诊断测试的使用以及检测样品中针对mpv的抗体的方法
4. isolated polypeptide, fusion protein, nucleic acid sequence, expression vector or a virus, recombinant cell, method of producing a soluble ectodomain polypeptide or fusion protein or fragment thereof, pharmaceutical composition, use of a monoclonal antibody or polyclonal or antigen-binding fragment thereof, use of antibody or antigen-binding fragment, use of any of an isolated polypeptide, method of regulating cytokines, induction of t-cell expansion, promotion of cell immunity antigen specific t and promotion of cd4 + and / or cd8 + t cell activation in a subject, method for enhancing an immune response secondary to an antigen in a patient, method of using at least one of: an isolated polypeptide, method for treatment or prevention of an immune system related condition, method for treating or preventing an infectious disease a, method for diagnosing a disease in a subject, method of producing a soluble ectodomain polypeptide tmem25, vsig10, ly6g6f, or fusion protein or fragment thereo [P] . BR112013026199A2 . 2017-11-07

机译：分离的多肽，融合蛋白，核酸序列，表达载体或病毒，重组细胞，产生可溶性胞外域多肽或融合蛋白或其片段的方法，药物组合物，单克隆抗体或其多克隆或抗原结合片段的用途，使用抗体或抗原结合片段，使用任何分离的多肽，调节细胞因子的方法，诱导t细胞扩增，促进细胞免疫抗原特异性t并促进cd4 +和/或cd8 + t细胞活化受试者，在患者中增强继发于抗原的免疫应答的方法，使用以下至少一种的方法：分离的多肽，用于治疗或预防与免疫系统有关的病症的方法，用于治疗或预防传染病的方法，用于诊断受试者疾病的方法，产生可溶性胞外域多肽tmem25，vsig10，ly6g6f或其融合蛋白或片段的方法
5. Modified immunoglobulin, molecule, isolated nucleic acid, cell containing the same, recombinant non-human animal, pharmaceutical composition, vaccine composition, processes for identifying or measuring or detecting a cancer antigen, an antigen from an infectious disease agent, a ligand, and a receptor in a sample. to be tested, kits for detecting a cancer antigen, an infectious disease agent antigen, a cell receptor for an infectious disease agent, a ligand, and a cancer antigen, diagnostic processes or testing for the presence of or a predisposition for the development of a cancer by the increased presence of a cancer antigen, and for the presence of an infectious disease, treatment or prevention of a cancer by the presence of a cancer antigen, of an infectious disease typified by the presence of an antigen infectious disease agent, and a disease caused by an infectious disease agent that binds to a cell receptor, processes for modulating activity of a first member of a binding pair, [P] . BR9815289A . 2001-12-26

机译：修饰的免疫球蛋白，分子，分离的核酸，含有相同免疫球蛋白的细胞，重组非人类动物，药物组合物，疫苗组合物，鉴定或测量或检测癌症抗原的方法，来自传染病原体的抗原，配体和样品中的受体。要测试的试剂盒，用于检测癌症抗原，传染病原体抗原，传染病原体的细胞受体，配体和癌症抗原的试剂盒，诊断过程或测试是否存在或易感通过增加癌症抗原的存在而引起的癌症，以及对于传染病的存在，通过癌症抗原的存在来治疗或预防癌症，以抗原传染病剂的存在为代表的传染病，以及由与细胞受体结合的传染病因子引起的疾病，调节结合对第一个成员的活性的过程，